Skip to content
Prime Palace offers curated insights on luxury living, home…

Zimbabwe Declines ‘One-Sided’ American Healthcare Assistance Package Due to Information Fears

Medical aid image
The proposed US financial assistance would have supported programmes for HIV/Aids treatment and prevention, TB, and malarial diseases.

The nation of Zimbabwe has declined a significant US healthcare agreement worth 367 million US dollars (272 million pounds) spanning five years because of Washington's demand for confidential biological samples.

This rejection was revealed following a official document dated December was leaked, indicating that Head of State Emmerson Mnangagwa believed the agreement was "skewed".

An official spokesman has since stated that the US was seeking biological samples for scientific study and commercial gain while refused to share the resulting advantages from any future medical innovations.

"We are forced to start the difficult and regrettable task of ending our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.

The US Embassy said the United States had provided over $1.9bn as health assistance to Zimbabwe over the last two decades.

A medical body in Zimbabwe has appealed for continued dialogue to reach a agreement acceptable to both sides so the country's vital HIV treatment initiative can continue.

Wider Background

This development comes after a similar case in neighbouring Kenya, where a high court blocked a similar health funding agreement after legal challenges were filed about the safety of Kenyans' health data.

Since resuming the presidency recently, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).

The agency had managed aid for the American government, but Trump argued its spending was "inefficient" and his administration was pursuing government-to-government deals to boost openness and responsibility.

Based on reports, Sixteen African countries have so far signed similar health pacts, constituting over $18.3bn of fresh investment.

Specifics of the Rejected Deal

The money for Zimbabwe would have supported "tackling HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.

"It is our view this partnership could have provided immense benefits for the people of Zimbabwe, especially the 1.2 million currently on HIV treatment via US-supported initiatives," Tremont said.

However, official spokesman Nick Mangwana said the arrangement was "unequal".

"Zimbabwe was being asked to share its genetic material and health information indefinitely, without any equivalent guarantee of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could result from that provided information," his statement read.

"Effectively, our country would provide the raw materials for scientific discovery with no certainty that the end products would be accessible to our citizens if a new disease outbreak arise."

Sovereignty and Global Health

He also pointed out that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were disrupting structures previously set up through the global health agency.

Mangwana cited its Pathogen Access and Benefit Sharing scheme created to deal with future global health emergencies.

"This system is intended to guarantee that when a nation contributes its samples, the benefits – including vaccines and treatments – are distributed fairly, not commercialised solely by those with the capability to create them."

The government's concerns regarding the US deal "should not be misconstrued as opposition to America," Mangwana stressed.

"We are open to further discussions with our American counterparts on how future collaboration might be designed in a manner that honours the sovereignty and dignity of each country."

Health Experts Response

The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the official position, but urged that talks should continue given that much of the country's HIV programmes relied on foreign aid.

"In cases where technical issues arise, such as those relating to data governance or agreement terms, these can frequently be addressed via detailed discussion and mutually agreed protections," the group said.

This impasse underscores the ongoing tensions between receiving crucial international aid and protecting national sovereignty in an ever more interconnected world.

About the author

Margaret Rios

Elara Vance is a lifestyle curator and design expert with over a decade of experience in luxury branding and interior aesthetics.

Prime Palace

Type to search articles.